Tell HIV patient that drug doesn cure virus or prevent its transmission and that opportunistic infections may occur. There is insufficient evidence to determine whether re-initiation of lamivudine alters the course of posttreatment exacerbations of hepatitis. Continue taking Epivir and talk to your doctor if you experience cough, dizziness, fatigue, stomach discomfort, headache, and trouble sleeping. Clinical Studies The use of EPIVIR is based on the results of clinical studies in HIV-1-infected patients in combination prieksstatu par epivir regimens with other antiretroviral agents. His announcements build on commitments unveiled in February aimed at expanding access to medicines and encouraging new research into diseases that disproportionately affect the world poorest countries. Pancreatitis is rare but serious side effect that can be life-threatening in some cases. In HIV- 1-infected MT-4 cells, lamivudine in combination with zidovudine at various ratios exhibited synergistic antiretroviral activity.